A Sour Cherry??? Christopher P. Cherry, the CFO of the Company, was a former director and officer of Lexagene Holdings Inc. (formerly Wolfeye Resource Corp.) (“Lexagene”). On August 7, 2013, the British Columbia Securities Commission (the “BCSC”) and the Alberta Securities Commission (the “Commissions”) issued a cease trade order (the “CTO”) against Lexagene, its directors, officers and insiders for failure of Lexagene to file its audited financial statements and management’s discussion & analysis and related certifications for the year ended March 31, 2013 (collectively, the “Financial Materials”). On August 8, 2013, trading in Lexagene’s common shares was suspended by the TSX Venture Exchange (“TSXV”) for failure to file the Financial Materials. Lexagene filed the Financial Materials with the Commissions and the CTO was lifted by the Commissions on September 26, 2013. Lexagene applied to the TSXV to lift the trading suspension and, after satisfying all of the conditions of the TSXV, the suspension was lifted and trading in Lexagene’s common shares recommenced on October 30, 2013.
Mr. Cherry is currently the CFO of Mexivada Mining Corp. (“Mexivada”). On October 29, 2010, at the request of management of Mexivada, the BCSC issued a CTO against the insiders of Mexivada for not filing comparative financial statements for its financial year ended June 30, 2010 and the related management’s discussion and analysis for the same period. The CTO was rescinded on November 30, 2010 and is no longer in effect. On October 31, 2011, at the request of management, the BCSC issued a CTO against the insiders of Mexivada for not filing comparative financial statements for its financial year ended June 30, 2011 and the related management’s discussion and analysis for the same period. The CTO was rescinded on November 24, 2011 and is no longer in effect. On October 31, 2012, at the request of management, the BCSC issued a CTO against the insiders of Mexivada for not filing comparative financial statements for its financial year ended June 30, 2012 and the related management’s discussion and analysis for the same period. The cease trade order is still in effect.
Mr. Cherry was a former director and officer of 1040426 BC Ltd., 1040433 BC Ltd., 1040440 BC Ltd., 1040442 BC Ltd. and Genix Pharmaceutical Corp., companies that are reporting issuers in the provinces of British Columbia and Alberta. On December 2, 2016, the BCSC issued a CTO against these companies, their directors, officers and insiders for failure to file audited financial statements and management’s discussion & analysis and related certifications for the year ended July 31, 2016. The BCSC also issued deficiency notices to each of 1040440 BC Ltd. and Genix Pharmaceutical Corp. for failure to file first quarter financial statements and management’s discussion & analysis for the period ended October 31, 2016. On May 23, 2017, the BCSC issued revocation orders for each of 1040426 BC Ltd., 1040433 BC Ltd. and 1040442 BC Ltd. and the CTOs were lifted. On September 20, 2017, the BCSC issued a revocation order for 1040440 BC Ltd. and the CTO was lifted. The CTO remains in effect for Genix Pharmaceutical Corp. (From the 2017 Management Circular as of Nov./17)
Seems like quite a rap sheet for the CFO from 2016 to 2019. Ivany was the CEO during that period. Coincidence??? Add to that a virtually unknown auditing firm!